{"id":43653,"date":"2022-08-03T07:13:07","date_gmt":"2022-08-03T07:13:07","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=43653"},"modified":"2022-10-14T20:35:31","modified_gmt":"2022-10-14T20:35:31","slug":"no-benefit-from-tdf-ftc-against-covid-19","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/43653","title":{"rendered":"No benefit from TDF\/FTC against COVID-19"},"content":{"rendered":"<div>\n<p class=\"HTBsubhead2articletitle\"><strong>Simon Collins, HIV i-Base<\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\" alignright\" src=\"https:\/\/i-base.info\/wp-content\/uploads\/2020\/03\/COVID-19-graphic.png\" width=\"231\" height=\"142\" \/>Results from this open-label, double-randomised, phase 3 study in 355 participants (97% hospitalised at baseline), reported no benefits from TDF\/FTC or from baricitinib on 28-day mortality.<\/span><\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\">Reference<\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\">Montejano R et al. on behalf of the PANCOVID study Group, Tenofovir disoproxil fumarate\/emtricitabine and baricitinib for patients at high risk of severe COVID-19: The PANCOVID Randomized Clinical Trial,\u00a0Clinical Infectious Diseases, 2022; ciac628,\u00a0doi:10.1093\/cid\/ciac628<span lang=\"EN-US\">. (30 July 2022).<br \/>\n<\/span><a href=\"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciac628\/6652179\">https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciac628\/6652179<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base Results from this open-label, double-randomised, phase 3 study in 355 participants (97% hospitalised at baseline), reported no benefits from TDF\/FTC or from baricitinib on 28-day mortality. Reference Montejano R et al. on behalf of the PANCOVID &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,283,278],"tags":[],"class_list":["post-43653","post","type-post","status-publish","format-standard","hentry","category-opportunistic-infections-coinfections-and-complications","category-covid-19-investigational-drugs","category-covid-19"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/43653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=43653"}],"version-history":[{"count":1,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/43653\/revisions"}],"predecessor-version":[{"id":44234,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/43653\/revisions\/44234"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=43653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=43653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=43653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}